Liminatus Pharma, Inc. (LIMN) - Latest Market Data

Price & Market Data

Price: $0.175

Daily Change: $0.00 / 0.00%

Daily Range: $0.159 - $0.192

Market Cap: $6,883,561

Daily Volume: 1,789,030

Performance Metrics

1 Week: -10.30%

1 Month: -29.15%

3 Months: -71.31%

6 Months: -89.88%

1 Year: -98.06%

YTD: -71.31%

Company Details

Employees: 3

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Liminatus Pharma, Inc. operates as a pre-clinical stage biopharmaceutical company that develops novel cancer therapies. It is developing CD47, a high affinity humanized anti CD47 antibody that has the potential to translate into clinic for CD47 SIRPa blocking and restoring the anti-tumor function of innate immune cells without inducing hemagglutination or hemolysis. The company was founded in 2018 is based in LA Palma, California.

Selected stocks

Revelation Biosciences, Inc. (REVB)

Xos, Inc. (XOS)

authID Inc. (AUID)